Impact of withdrawal from market on the pattern of cyclooxygenase-2 inhibitors reported to Texas poison control centers

References

• Konstantinopoulos , PA and Lehmann , DF . 2005 . The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: Comparisons, contrasts, and aspirin confounding . J Clin Pharmacol , 45 : 742 – 750 .
   PubMed Web of Science ®Google Scholar
• Spalding , WM , Reeves , MJ and Whelton , A . 2007 . Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs . Am J Ther , 14 : 3 – 12 .
   PubMedGoogle Scholar
• Motsko , SP , Rascati , KL , Busti , AJ , Wilson , JP , Barner , JC , Lawson , KA and Worchel , J . 2006 . Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk . Drug Safety , 29 : 621 – 632 .
   PubMed Web of Science ®Google Scholar
• Bresalier , RS , Sandler , RS , Quan , H , Bolognese , JA , Oxenius , B , Horgan , K , Lines , C , Riddell , R , Morton , D Lanas , A . 2005 . Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial . N Engl J Med , 352 : 1092 – 1102 .
   PubMed Web of Science ®Google Scholar
• Graham , DJ , Campen , D , Hui , R , Spence , M , Cheetham , C , Levy , G , Shoor , S and Ray , WA . 2005 . Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested case-control study . Lancet , 365 : 475 – 481 .
   PubMed Web of Science ®Google Scholar
• Bombardier , C , Laine , L , Reicin , A , Shapiro , D , Burgos-Vargas , R , Davis , B , Day , R , Ferraz , MB , Hawkey , CJ Hochberg , MC . 2000 . Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis . N Engl J Med , 343 : 1520 – 1528 .
   PubMed Web of Science ®Google Scholar
• Nussmeier , NA , Whelton , AA , Brown , MT , Langford , RM , Hoeft , A , Parlow , JL , Boyce , SW and Verburg , KM . 2005 . Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery . N Engl J Med , 352 : 1081 – 1091 .
   PubMed Web of Science ®Google Scholar
• Solomon , SD , McMurray , JJ , Pfeffer , MA , Wittes , J , Fowler , R , Finn , P , Anderson , WF , Zauber , A , Hawk , E Bertagnolli , M . 2005 . Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention . N Engl J Med , 352 : 1071 – 1080 .
   PubMed Web of Science ®Google Scholar
• White , WB , West , CR , Borer , JS , Gorelick , PB , Lavange , L , Pan , SX , Weiner , E and Verburg , KM . 2007 . Risk of cardiovascular events in patients receiving celecoxib: A meta-analysis of randomized clinical trials . Am J Cardiol , 99 : 91 – 98 .
   PubMed Web of Science ®Google Scholar
• Silverstein , FE , Faich , G , Goldstein , JL , Simon , LS , Pincus , T , Whelton , A , Makuch , R , Eisen , G , Agrawal , NM Stenson , WF . 2000 . Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib long-term arthritis safety study . J Am Med Assoc , 284 : 1247 – 1255 .
   PubMed Web of Science ®Google Scholar
• Tanne , JH . 2005 . Merck faces ongoing claims after Texan ruling on rofecoxib . Br Med J , 331 : 471
   PubMedGoogle Scholar
• Mayor , S . 2005 . Merck cleared in personal injury case against Vioxx . Br Med J , 331 : 1101
   PubMedGoogle Scholar
• Forrester , MB . 2006 . Celecoxib exposures reported to Texas poison control centers from 1999 to 2004 . Human Exp Toxicol , 25 : 261 – 266 .
   PubMedGoogle Scholar
• Forrester , MB . 2006 . Valdecoxib exposures reported to Texas poison centers during 2002–2004 . J Toxicol Environ Health A. , 69 : 899 – 905 .
   PubMed Web of Science ®Google Scholar
• Litovitz , TL , Klein-Schwartz , W , Rodgers , GC , Cobaugh , DJ , Youniss , J , Omslaer , JC , May , ME , Woolf , AD and Benson , BE . 2002 . 2001 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am J Emerg Med , 20 : 391 – 452 .
   PubMed Web of Science ®Google Scholar
• Watson , WA , Litovitz , TL , Rodgers , GC , Klein-Schwartz , W , Youniss , J , Rose , SR , Borys , D and May , ME . 2003 . 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am J Emerg Med , 21 : 353 – 421 .
   PubMed Web of Science ®Google Scholar
• Watson , WA , Litovitz , TL , Klein-Schwartz , W , Rodgers , GC , Youniss , J , Reid , N , Rouse , WG , Rembert , RS and Borys , D . 2004 . 2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am J Emerg Med , 22 : 335 – 404 .
   PubMed Web of Science ®Google Scholar
• Watson , WA , Litovitz , TL , Rodgers , GC , Klein-Schwartz , W , Reid , N , Youniss , J , Flanagan , A and Wruk , KM . 2005 . 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System . Am J Emerg Med , 23 : 589 – 666 .
   PubMed Web of Science ®Google Scholar
• Lai , MW , Klein-Schwartz , W , Rodgers , GC , Abrams , JY , Haber , DA , Bronstein , AC and Wruk , KM . 2006 . 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database . Clin Toxicol , 44 : 803 – 932 .
   PubMed Web of Science ®Google Scholar
• Seifert , SA , Jacobitz , K , Ling , L , Bangh , S , Bronstein , AC and Lansinger , PA . 2004 . Valdecoxib (Bextra(R)) overdose: A case series . J Toxicol Clin Toxicol , 42 : 723
   Google Scholar
• Forrester , MB . 2005 . Impact of legislation on illicit substance surveillance by poison centers in Texas . J Registry Manage , 32 : 118 – 123 .
   Google Scholar
• Forrester , MB . 2006 . Aripiprazole exposures reported to Texas poison control centers during 2002–2004 . J Toxicol Environ Health A , 69 : 1719 – 1726 .
   PubMed Web of Science ®Google Scholar
• Forrester , MB . 2006 . Pattern of dipyrone exposure in Texas, 1998 to 2004 . J Med Toxicol , 2 : 101 – 107 .
   PubMedGoogle Scholar